Pathstone Family Office, LLC Ginkgo Bioworks Holdings, Inc. Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
A detailed history of Pathstone Family Office, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Pathstone Family Office, LLC holds 161,777 shares of DNA stock, worth $53,386. This represents 0.0% of its overall portfolio holdings.
Number of Shares
161,777
Previous 90,464
78.83%
Holding current value
$53,386
Previous $168,000
73.81%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DNA
# of Institutions
359Shares Held
1.26BCall Options Held
845KPut Options Held
2.54M-
Baillie Gifford & CO233MShares$76.9 Million0.21% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl190MShares$62.6 Million1.57% of portfolio
-
Viking Global Investors LP143MShares$47.2 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA126MShares$41.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY72.9MShares$24 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $425M
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...